Back to search
High Risk Meningioma
Clinical trial pipeline · Data from ClinicalTrials.gov
See which High Risk Meningioma trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which High Risk Meningioma trials you may qualify forStudy in children and adolescents of 177Lu DOTATATE (Lutathera®) combined with the PARP inhibitor olaparib for treatment of recurrent or relapsed solid tumours…
This study will evaluate the safety and efficacy of Lutathera (177Lu-DOTATATE) in patients with progressive or recurrent High-Grade Central Nervous System (CNS)…
This multi-site, Phase 2 clinical trial is an open-label study to identify the safety, pharmacokinetics, and efficacy of a repeated dose regimen of NEO100 (peri…
The objective of this protocol is to develop an institution-wide liquid biopsy protocol that will establish a common process for collecting blood and correspond…
High-risk meningiomas always require postsurgical radiation treatment. Recent evidence has shown that increased radiation therapy dose may be associated with in…
This research study is studying radiation therapy as a possible treatment for meningioma or tumor on the lining of the brain. The study drug or intervention inv…
This phase I/II trial studies the side effects and best dose of nivolumab when given together with multi-fraction stereotactic radiosurgery and to see how well…